Certara, Inc. (NASDAQ:CERT) Receives $15.42 Consensus Price Target from Brokerages

Certara, Inc. (NASDAQ:CERT) has been given a consensus recommendation of “Moderate Buy” by the eight ratings firms that are presently covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $15.83.

Several research firms have recently issued reports on CERT. TD Cowen began coverage on shares of Certara in a report on Thursday, February 27th. They set a “buy” rating and a $16.00 target price for the company. Barclays lifted their target price on shares of Certara from $12.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, February 28th. William Blair reiterated a “market perform” rating on shares of Certara in a report on Thursday, February 27th. Finally, Stephens reiterated an “overweight” rating and set a $17.00 target price on shares of Certara in a report on Thursday, February 27th.

Institutional Investors Weigh In On Certara

Several institutional investors and hedge funds have recently made changes to their positions in CERT. Venturi Wealth Management LLC increased its position in shares of Certara by 839.1% during the fourth quarter. Venturi Wealth Management LLC now owns 2,808 shares of the company’s stock valued at $30,000 after acquiring an additional 2,509 shares in the last quarter. Wells Fargo & Company MN increased its position in shares of Certara by 48.4% during the fourth quarter. Wells Fargo & Company MN now owns 3,208 shares of the company’s stock valued at $34,000 after acquiring an additional 1,047 shares in the last quarter. Blue Trust Inc. grew its position in Certara by 112.3% in the 3rd quarter. Blue Trust Inc. now owns 3,925 shares of the company’s stock worth $46,000 after purchasing an additional 2,076 shares during the period. Johnson Financial Group Inc. bought a new stake in Certara in the 4th quarter worth approximately $47,000. Finally, KBC Group NV grew its position in Certara by 48.2% in the 3rd quarter. KBC Group NV now owns 4,873 shares of the company’s stock worth $57,000 after purchasing an additional 1,584 shares during the period. Institutional investors own 73.96% of the company’s stock.

Certara Stock Performance

Shares of CERT opened at $11.91 on Thursday. The company has a 50-day simple moving average of $12.52 and a two-hundred day simple moving average of $11.63. Certara has a one year low of $9.41 and a one year high of $19.87. The firm has a market capitalization of $1.92 billion, a PE ratio of -59.55, a price-to-earnings-growth ratio of 9.29 and a beta of 1.60. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.